FDA “First Generics” Policy Not Enough, Mylan CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency's ANDA review needs a top-to-bottom policy overhaul to end approval delays, Coury says.
You may also be interested in...
J&J Ditropan XL Goes Generic
Impax/Teva launching 15 mg strength, and Mylan joins with "authorized" generic as well as its own version of the 5 mg and 10 mg strengths.
J&J Ditropan XL Goes Generic
Impax/Teva launching 15 mg strength, and Mylan joins with "authorized" generic as well as its own version of the 5 mg and 10 mg strengths.
Mylan Undaunted By Other Duragesic Generics
Fentanyl patch competitors have yet to deliver the product dependably, says Mylan CEO.